CDKN1A, cyclin dependent kinase inhibitor 1A, 1026

N. diseases: 490; N. variants: 17
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.260 Biomarker disease RGD Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models. 23890812 2014
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.260 AlteredExpression disease BEFREE Furthermore, immunohistochemical analysis of a panel of thyroid tumours characterised by different aggressiveness showed that the expression of OIS markers such as p16(INK4a), p21(CIP1) and IGFBP7 is upregulated at early stages, and lost during thyroid tumour progression. 21937739 2011
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.260 Biomarker disease LHGDN BRL upregulated the p21Cip1/WAF1 levels in the two thyroid cancer cells, while did not modify the p53 protein content. 18509005 2008
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.260 Biomarker disease LHGDN Expression of p21cip1, p27kip1, and p16INk4a cyclin-dependent kinase inhibitors in papillary thyroid carcinoma: correlation with clinicopathological factors. 18766473 2008
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.260 AlteredExpression disease LHGDN Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression. 17188136 2006
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.260 AlteredExpression disease BEFREE Alterations of p53 and expression of WAF1/p21 in human thyroid tumors. 8777377 1996
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.260 GeneticVariation disease BEFREE We, therefore, examined a series of 57 thyroid tumour specimens (eight follicular adenomas and 49 carcinomas) for deletion and point mutation of the p21/Waf1 gene. 8912526 1996